Active Ingredient: LOTEPREDNOL ETABONATE; TOBRAMYCIN
Proprietary Name: ZYLET
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.5%;0.3%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N050804
Product Number: 001
Approval Date: Dec 14, 2004
Applicant Holder Full Name: BAUSCH AND LOMB INC
Marketing Status:
Prescription
Patent and Exclusivity Information